Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)

ClinicalTrials.gov ID: NCT04442503

Public ClinicalTrials.gov record NCT04442503. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-controlled Study Evaluating the Efficacy and Safety of SAGE-217 in the Treatment of Adults With Severe Postpartum Depression

Study identification

NCT ID
NCT04442503
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Biogen
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

  • SAGE-217 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 7, 2020
Primary completion
Mar 14, 2022
Completion
Apr 11, 2022
Last update posted
Nov 29, 2023

2020 – 2022

United States locations

U.S. sites
68
U.S. states
27
U.S. cities
65
Facility City State ZIP Site status
Sage Investigational Site Scottsdale Arizona 85258
Sage Investigational Site Bentonville Arkansas 72712
Sage Investigational Site Anaheim California 92805
Sage Investigational Site Bellflower California 90706
Sage Investigational Site Beverly Hills California 90212
Sage Investigational Site Costa Mesa California 92627
Sage Investigational Site Imperial California 92251
Sage Investigational Site Lemon Grove California 91945
Sage Investigational Site Norwalk California 90650
Sage Investigational Site Oceanside California 92056
Sage Investigational Site Orange California 92866
Sage Investigational Site Orange California 92868
Sage Investigational Site Redlands California 92374
Sage Investigational Site San Bernardino California 92408
Sage Investigational Site Sherman Oaks California 91403
Sage Investigational Site Torrance California 90502
Sage Investigational Site Aurora Colorado 80045
Sage Investigational Site Norwich Connecticut 06360
Sage Investigational Site Boynton Beach Florida 33435
Sage Investigational Site Hialeah Florida 33012
Sage Investigational Site Jacksonville Florida 32256
Sage Investigational Site Miami Florida 33133
Sage Investigational Site Miami Springs Florida 33166
Sage Investigational Site Miramar Florida 33029
Sage Investigational Site Orlando Florida 32801
Sage Investigational Site Orlando Florida 32807
Sage Investigational Site Pensacola Florida 35202
Sage Investigational Site Pinellas Park Florida 33872
Sage Investigational Site Pompano Beach Florida 33060
Sage Investigational Site Alpharetta Georgia 30022
Sage Investigational Site Atlanta Georgia 30331
Sage Investigational Site Decatur Georgia 30030
Sage Investigational Site Savannah Georgia 31405
Sage Investigational Site Idaho Falls Idaho 83404
Sage Investigational Site Hoffman Estates Illinois 60169
Sage Investigational Site Lincolnwood Illinois 60712
Sage Investigational Site Wichita Kansas 67226
Sage Investigational Site New Orleans Louisiana 70115
Sage Investigational Site Boston Massachusetts 02114
Sage Investigational Site Detroit Michigan 48201
Sage Investigational Site Flowood Mississippi 39232
Sage Investigational Site Saint Charles Missouri 63304
Sage Investigational Site St Louis Missouri 63125
Sage Investigational Site St Louis Missouri 63128
Sage Investigational Site Las Vegas Nevada 89102
Sage Investigational Site Marlton New Jersey 08053
Sage Investigational Site Brooklyn New York 11229
Sage Investigational Site Glen Oaks New York 11004
Sage Investigational Site New York New York 10036
Sage Investigational Site Chapel Hill North Carolina 27599
Sage Investigational Site Charlotte North Carolina 28211
Sage Investigational Site Denver North Carolina 28037
Sage Investigational Site Beachwood Ohio 44122
Sage Investigational Site Mayfield Heights Ohio 44124
Sage Investigational SIte North Canton Ohio 44720
Sage Investigational Site Oklahoma City Oklahoma 73112
Sage Investigational Site Allentown Pennsylvania 18104
Sage Investigational Site Moosic Pennsylvania 18507
Sage Investigational Site Providence Rhode Island 02904
Sage Investigational site Charleston South Carolina 29425
Sage Investigational Site Dallas Texas 75231
Sage Investigational Site Fort Worth Texas 76104
Sage Investigational Site Houston Texas 77058
Sage Investigational Site League City Texas 77573
Sage Investigational Site Richardson Texas 75080
Sage Investigational Site San Antonio Texas 78229
Sage Investigational Site North Chesterfield Virginia 23235
Sage Investigational Site Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04442503, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 29, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04442503 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →